❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ G. Mælandsmo's group ❭ Links ❭

Links

Search engines
  • Lycos
  • WhoWhere?
  • ABC startsiden
  • Allltheweb
  • Finn.no
  • Start.no
  • Twingine (Yagoohoogle)
  • Yahoo
  • Google
 Reference books
  • Telefonkatalogen
  • Britannica.com
  • Merriam-Webster
  • Wikipedia
  • Trafikanten

 

  • Forskernett Links
 Only from MR PCs or using VPN
  • IT info/status
  • Mittskrivebord
  • Personalportalen
  • Kompetanseutvikling
  • Telefonkatalogen
  • Servicedesk
  • EK Kvalitet
 Miscellaneous
  • The Norwegian Cancer Society
  • Universitetet i Oslo
  • The Norwegian Radium Hospital
  • Rikshospitalet
  • Helsenett
  • Forskningsrådet
  • Aftenposten
  • Dagbladet
  • VG
  • Virtual Oslo
  • NBS
  • Valutakalkulator
  • The ELSO
  • Meteorological Institute

 E-mail
  • Webmail UIO
  • Webmail Forskernett
     
  • Hotmail
  • Yahoo Mail
  • Gmail
Scroll to top

Home Dept. of Tumor Biology G. Mælandsmo's group

  • Research interests
  • Group members
  • Publications
  • Links

Recent publications

Normann LS, Haugen MH, Hongisto V, Aure MR, Leivonen SK, Kristensen VN, Tahiri A, Engebraaten O, Sahlberg KK, Mælandsmo GM (2023)
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
PLoS One, 18 (1), e0280507
DOI 10.1371/journal.pone.0280507, PubMed 36706086

Nunes-Xavier CE, Emaldi M, Guldvik IJ, Ramberg H, Taskén KA, Mælandsmo GM, Fodstad Ø, Llarena R, Pulido R, López JI (2022)
Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer
Pathol Res Pract, 241, 154243
DOI 10.1016/j.prp.2022.154243, PubMed 36481650

Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H, Kristensen G, Tennstedt P, Røder A, Schlomm T, Berge V, Eri LM, Lilleby W, Mills IG, Taskén KA (2022)
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
Eur Urol Open Sci, 45, 68-75
DOI 10.1016/j.euros.2022.09.002, PubMed 36353660



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)